Novel minor groove binders cure animal African trypanosomiasis in an in vivo mouse model

Federica Giordani, Abedawn I. Khalaf, Kirsten Gillingwater, Jane C. Munday, Harry P. De Koning, Colin J. Suckling, Michael P. Barrett, Fraser J. Scott

Research output: Contribution to journalArticle

Abstract

Animal African trypanosomiasis (AAT) is a significant socioeconomic burden for sub-Saharan Africa because of its huge impact on livestock health. Existing therapies including those based on minor groove binders (MGBs), such as the diamidines, which have been used for decades, have now lost efficacy in some places because of the emergence of resistant parasites. Consequently, the need for new chemotherapies is urgent. Here, we describe a structurally distinct class of MGBs, Strathclyde MGBs (S-MGBs), which display excellent in vitro activities against the principal causative organisms of AAT: Trypanosoma congolense, and Trypanosoma vivax. We also show the cure of T. congolense-infected mice by a number of these compounds. In particular, we identify S-MGB-234, compound 7, as curative by using two applications of 50 mg/kg intraperitoneally. Crucially, we demonstrate that S-MGBs do not show cross-resistance with the current diamidine drugs and are not internalized via the transporters used by diamidines. This study demonstrates that S-MGBs have significant potential as novel therapeutic agents for AAT.

LanguageEnglish
Pages3021-3035
Number of pages15
JournalJournal of Medicinal Chemistry
Volume62
Issue number6
Early online date14 Feb 2019
DOIs
Publication statusPublished - 28 Mar 2019

Fingerprint

African Trypanosomiasis
Pentamidine
Trypanosoma congolense
Trypanosoma vivax
Africa South of the Sahara
Livestock
Parasites
Drug Therapy
Health
Therapeutics
Pharmaceutical Preparations

Keywords

  • animal African trypanosomiasis
  • nagana
  • cattle disease

Cite this

Giordani, Federica ; Khalaf, Abedawn I. ; Gillingwater, Kirsten ; Munday, Jane C. ; De Koning, Harry P. ; Suckling, Colin J. ; Barrett, Michael P. ; Scott, Fraser J. / Novel minor groove binders cure animal African trypanosomiasis in an in vivo mouse model. In: Journal of Medicinal Chemistry. 2019 ; Vol. 62, No. 6. pp. 3021-3035.
@article{556c7401520141159b74372ea161719f,
title = "Novel minor groove binders cure animal African trypanosomiasis in an in vivo mouse model",
abstract = "Animal African trypanosomiasis (AAT) is a significant socioeconomic burden for sub-Saharan Africa because of its huge impact on livestock health. Existing therapies including those based on minor groove binders (MGBs), such as the diamidines, which have been used for decades, have now lost efficacy in some places because of the emergence of resistant parasites. Consequently, the need for new chemotherapies is urgent. Here, we describe a structurally distinct class of MGBs, Strathclyde MGBs (S-MGBs), which display excellent in vitro activities against the principal causative organisms of AAT: Trypanosoma congolense, and Trypanosoma vivax. We also show the cure of T. congolense-infected mice by a number of these compounds. In particular, we identify S-MGB-234, compound 7, as curative by using two applications of 50 mg/kg intraperitoneally. Crucially, we demonstrate that S-MGBs do not show cross-resistance with the current diamidine drugs and are not internalized via the transporters used by diamidines. This study demonstrates that S-MGBs have significant potential as novel therapeutic agents for AAT.",
keywords = "animal African trypanosomiasis, nagana, cattle disease",
author = "Federica Giordani and Khalaf, {Abedawn I.} and Kirsten Gillingwater and Munday, {Jane C.} and {De Koning}, {Harry P.} and Suckling, {Colin J.} and Barrett, {Michael P.} and Scott, {Fraser J.}",
year = "2019",
month = "3",
day = "28",
doi = "10.1021/acs.jmedchem.8b01847",
language = "English",
volume = "62",
pages = "3021--3035",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

Novel minor groove binders cure animal African trypanosomiasis in an in vivo mouse model. / Giordani, Federica; Khalaf, Abedawn I.; Gillingwater, Kirsten; Munday, Jane C.; De Koning, Harry P.; Suckling, Colin J.; Barrett, Michael P.; Scott, Fraser J.

In: Journal of Medicinal Chemistry, Vol. 62, No. 6, 28.03.2019, p. 3021-3035.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel minor groove binders cure animal African trypanosomiasis in an in vivo mouse model

AU - Giordani, Federica

AU - Khalaf, Abedawn I.

AU - Gillingwater, Kirsten

AU - Munday, Jane C.

AU - De Koning, Harry P.

AU - Suckling, Colin J.

AU - Barrett, Michael P.

AU - Scott, Fraser J.

PY - 2019/3/28

Y1 - 2019/3/28

N2 - Animal African trypanosomiasis (AAT) is a significant socioeconomic burden for sub-Saharan Africa because of its huge impact on livestock health. Existing therapies including those based on minor groove binders (MGBs), such as the diamidines, which have been used for decades, have now lost efficacy in some places because of the emergence of resistant parasites. Consequently, the need for new chemotherapies is urgent. Here, we describe a structurally distinct class of MGBs, Strathclyde MGBs (S-MGBs), which display excellent in vitro activities against the principal causative organisms of AAT: Trypanosoma congolense, and Trypanosoma vivax. We also show the cure of T. congolense-infected mice by a number of these compounds. In particular, we identify S-MGB-234, compound 7, as curative by using two applications of 50 mg/kg intraperitoneally. Crucially, we demonstrate that S-MGBs do not show cross-resistance with the current diamidine drugs and are not internalized via the transporters used by diamidines. This study demonstrates that S-MGBs have significant potential as novel therapeutic agents for AAT.

AB - Animal African trypanosomiasis (AAT) is a significant socioeconomic burden for sub-Saharan Africa because of its huge impact on livestock health. Existing therapies including those based on minor groove binders (MGBs), such as the diamidines, which have been used for decades, have now lost efficacy in some places because of the emergence of resistant parasites. Consequently, the need for new chemotherapies is urgent. Here, we describe a structurally distinct class of MGBs, Strathclyde MGBs (S-MGBs), which display excellent in vitro activities against the principal causative organisms of AAT: Trypanosoma congolense, and Trypanosoma vivax. We also show the cure of T. congolense-infected mice by a number of these compounds. In particular, we identify S-MGB-234, compound 7, as curative by using two applications of 50 mg/kg intraperitoneally. Crucially, we demonstrate that S-MGBs do not show cross-resistance with the current diamidine drugs and are not internalized via the transporters used by diamidines. This study demonstrates that S-MGBs have significant potential as novel therapeutic agents for AAT.

KW - animal African trypanosomiasis

KW - nagana

KW - cattle disease

UR - http://www.scopus.com/inward/record.url?scp=85063165937&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b01847

DO - 10.1021/acs.jmedchem.8b01847

M3 - Article

VL - 62

SP - 3021

EP - 3035

JO - Journal of Medicinal Chemistry

T2 - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -